Dr. Lal PathLabs Limited
LALPATHLAB
Rang in Aktien
#4509
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Aktienkurs
$20.35
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$3.40B
Veränderung (1 Tag)
-0.86%
Veränderung (1 Jahr)
13.63%
Land
IN
Handel Dr. Lal PathLabs Limited (LALPATHLAB)
Kategorie
Healthcare
P/B-Verhältnis für Dr. Lal PathLabs Limited (LALPATHLAB)
P/B-Verhältnis zum October 2026 TTM: 12.30
Laut den neuesten Finanzberichten und dem Aktienkurs von Dr. Lal PathLabs Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 12.30. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 10.30.
P/B-Verlauf für Dr. Lal PathLabs Limited von 2011 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 12.30 | 33.57% |
| 2025 | 9.21 | -10.56% |
| 2024 | 10.30 | 13.24% |
| 2023 | 9.09 | -36.47% |
| 2022 | 14.31 | -20.24% |
| 2021 | 17.95 | 60.49% |
| 2020 | 11.18 | 22.31% |
| 2019 | 9.14 | 1.33% |
| 2018 | 9.02 | -24.30% |
| 2017 | 11.92 | -20.38% |
| 2016 | 14.97 | 14.51% |
| 2015 | 13.07 | -55.61% |
| 2014 | 29.45 | -29.99% |
| 2013 | 42.07 | -28.44% |
| 2012 | 58.79 | -19.94% |
| 2011 | 73.44 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| 4.7411 | -61.46% |
US
|
|
| 3.0143 | -75.50% |
US
|
|
| 31.051 | 152.42% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | -45.83% |
US
|
